Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds
L Havlicek, J Hanuš, J Veselý, S Leclerc…
Index: Journal of Medicinal Chemistry, , vol. 40, # 4 p. 408 - 412
Full Text: HTML
Citation Number: 246
Abstract
... Journal of Medicinal Chemistry. ... Central Radioisotope Laboratory, Medical Faculty 1, Charles University, Na bojišti 3, 121 08 Prague 2, Czech Republic, Isotope Laboratory, Institute of Experimental Botany, Vídeňská 1083, 142 20 Prague 4, Czech Republic, Department of ...
Related Articles:
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors
[Wilson, Stuart C.; Atrash, Butrus; Barlow, Clare; Eccles, Susan; Fischer, Peter M.; Hayes, Angela; Kelland, Lloyd; Jackson, Wayne; Jarman, Michael; Mirza, Amin; Moreno, Javier; Nutley, Bernard P.; Raynaud, Florence I.; Sheldrake, Peter; Walton, Mike; Westwood, Robert; Whittaker, Steven; Workman, Paul; McDonald, Edward Bioorganic and Medicinal Chemistry, 2011 , vol. 19, # 22 p. 6949 - 6965]
Practical synthesis of roscovitine and CR8
[Oumata, Nassima; Ferandin, Yoan; Meijer, Laurent; Galons, Herve Organic Process Research and Development, 2009 , vol. 13, # 3 p. 641 - 644]
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors
[Bioorganic and Medicinal Chemistry, , vol. 19, # 22 p. 6949 - 6965]
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors
[Bioorganic and Medicinal Chemistry, , vol. 19, # 22 p. 6949 - 6965]
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors
[Bioorganic and Medicinal Chemistry, , vol. 19, # 22 p. 6949 - 6965]